Home > Waters Kraus > Offices > Office Profile

Waters & Kraus, LLP

  - Office Profile

                  Firm Logo for Waters Kraus LLP
Waters & Kraus, LLP 
Dallas, Texas Office
View all offices

3219 McKinney Avenue
Dallas, Texas  75204

(Collin, Dallas & Denton Cos.)

Telephone: 214.357.6244
Toll Free: 800.226.9880
Telecopier: 214.357.7252
URL: http://www.mesothelioma-legal-firm.com


Profile Visibility
#2 in weekly profile views out of 3,037 law firms in Dallas, Texas
#192 in weekly profile views out of 282,726 total law firms Overall

Office Hours:
Monday: 08:00 AM-05:00 PM
Tuesday: 08:00 AM-05:00 PM
Wednesday: 08:00 AM-05:00 PM
Thursday: 08:00 AM-05:00 PM
Friday: 08:00 AM-05:00 PM

About this office:

Waters & Kraus, LLP is a mid-sized plaintiffs' firm with a successful national practice, as well as international experience. Our attorneys focus on toxic tort litigation (asbestos/mesothelioma), consumer product liability, as well as qui tam (whistleblower) and commercial litigation. With offices in Texas and California, Waters & Kraus, LLP has litigated cases in jurisdictions across the United States on behalf of individuals from all 50 states, as well as foreign governments. To learn more about the firm and our practice, please go to www.waterskraus.com.


Statement of Practice Summary:
Mesothelioma; Asbestos Cancer; Civil Law; Class Actions; Qui Tam; Pharmaceutical; Product Liability; Toxic Torts; Asbestos Litigation; Whistleblower Litigation; International Litigation; Drug and Medical Device Litigation; Dental Medicaid Fraud; Medicare Fraud and Abuse; Birth and Childhood Injury.

Documents by Lawyers at this office
Subscribe to this feed

C.R. Bard Reaches $200 Million Transvaginal Mesh Settlement
Kyla Gail Cole, September 15, 2015
Transvaginal mesh maker C.R. Bard Inc. has reached an agreement to settle 3,000 vaginal mesh lawsuits for more than $200 million. The settlement averages out to $67,000 per case.

Standard Chemotherapy Regimen for Pleural Mesothelioma May Add Bevacizumab
Peter A. Kraus,Troyce G. Wolf, June 24, 2015
Malignant pleural mesothelioma may soon be getting a new standard of care. Bevacizumab may be added to the current standard chemotherapy regimen of pemetrexed and cisplatin. According to Dr. Gerald Zalcman, who recently presented a paper at the 2015 American Society of Clinical Oncology (ASCO)...

Mesothelioma Patients May Benefit From Lymphoma Drug
Peter A. Kraus,Troyce G. Wolf, April 22, 2015
Mesothelioma patients whose disease is of the epithelioid subtype may benefit from treatment with a drug that is already being used in patients with large cell lymphoma and Hodgkin’s disease. Adcetris — or brentuximab vedotin — has been shown in encouraging new research to slow...

Year Established: 1995

Languages: English and Spanish.

Return to the Waters & Kraus, LLP Firm Overview


Complete a Client Review

Have you recently worked with this firm? Share your experience as a Client of this firm and complete a Client Review to help others make an informed choice when hiring legal counsel.

Compare this Firm

Compare this firm to other firms in your Favorites.

Add firm to Favorites

As a registered user of martindale.com Connected, you can add firms to your list of Favorites. You can securely add comments and compare the firms in your Favorites.